Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mnpharm
AddedFeb 19, 2024
UpdatedJun 18, 2026
Mnpharm

Mnpharm

MNPHARM leverages advanced genetic engineering and indoor farming to produce affordable, high-quality recombinant proteins for regenerative medicine.

HQ
White Bear Lake, MN, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize protein production, MNPHARM leverages advanced genetic engineering and controlled indoor agriculture to produce high-quality, affordable recombinant proteins. The company focuses on the regenerative medicine market, aiming to lower the costs of essential proteins for therapeutic development. Their proprietary plant-based protein expression methods ensure rapid and efficient production, catering primarily to the research community.

MNPHARM's notable achievements include the successful production of VEGF-165 and PLAP/AALP proteins, which are critical in regenerative therapies. The company has attracted significant interest from investors focused on biotech innovations. By eliminating animal components from their production process, MNPHARM not only enhances safety but also sets new standards in the industry. Their impact is marked by making cutting-edge regenerative treatments more accessible and affordable.

Mnpharm - Similar Companies

PhylloTech logo

PhylloTech

Future Fields logo

Future Fields

futurefields.io

PlantPharm BioMed logo

PlantPharm BioMed

plantpharm.biz

Juvena Therapeutics logo

Juvena Therapeutics

AI Proteins logo

AI Proteins

aiproteinstx.com

Transgenrx logo

Transgenrx

GreenLab logo

GreenLab

greenlab.com

Recombinetics logo

Recombinetics

recombinetics.com

Ventria Bioscience logo

Ventria Bioscience

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

pH Pharma logo

pH Pharma

ph-pharma.com

MBC Pharma logo

MBC Pharma

mbcpharma.com

Manus Bio logo

Manus Bio

Phytomedics logo

Phytomedics

Sunflower Therapeutics logo

Sunflower Therapeutics

sunflowertx.com

Mnpharm - Quick Facts

Who are Mnpharm's competitors?

Companies similar to Mnpharm include PhylloTech, Future Fields, PlantPharm BioMed and Juvena Therapeutics.

When was Mnpharm founded?

Mnpharm was founded in 2015.

Where is Mnpharm's headquarters located?

Mnpharm's headquarters is located in White Bear Lake, MN, US.

How much has Mnpharm raised to-date?

As of Jun 5, 2023, Mnpharm has raised a total of $400k (USD).

How many employees does Mnpharm have?

Mnpharm has 6 employees as of Feb 4, 2024.

Mnpharm - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Recombinant Proteins
Tags
  • Agriculture
  • Biotech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software